Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
No one on the platform currently holds DIZTF.
No tracked institution reports a position in DIZTF as of their last filing.
No one on the platform has traded DIZTF yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $133M | +32.1% | $0.19 | $0.19–$0.19 | 1.2× | 1 |
| 2027 | $169M | +27.1% | $0.28 | $0.28–$0.28 | 0.8× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 2 of the last 2 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2024-11-21 | $-0.01 | $-0.00 | +80.8% |
| 2024-02-15 | $-0.01 | $-0.01 | +27.8% |
| $19M |
| — |
| KBBTFKubota Pharmaceutical Holdings Co., Ltd. | $0.96 | +0.00% | $24M | — |
| SRNEQSorrento Therapeutics, Inc. | $0.03 | +3.45% | $17M | — |
Source: Financial Modeling Prep · peers by sector/industry